REVIEW ARTICLE
Year : 2022 | Volume
: 6 | Issue : 1 | Page : 1--6
Hepatitis B virus-related nephropathy: Review and update
Elmukhtar Habas1, Fahim Khan1, Khalifa Farfar2, Aml Habas3, Aisha Al Aldab1, Mehdi Errayes4, Eshrak Habas5, Ijaz Kamal4, Amnna Rayani3, Abdel-Naser Elzouki6
1 Internal Medicine, Hamad General Hospital, Doha-, Qatar
2 Alwakar Hospital, Alwakra, Alwakra-, Qatar
3 Department of Medical, Tripoli Medical Center, Tripoli-, Libya
4 Internal Medicine, Hamad General Hospital, Doha, Qatar
5 Tripoli Medical Center, Tripoli University, Tripoli, Libya
6 Hamad Medical Corporation
Correspondence Address:
Prof. Elmukhtar Habas
Internal Medicine, Hamad General Hospital, Doha
Qatar
Viral-associated nephropathy indicates the direct pathogenic relationship between viral status and the development of nephropathy. Hepatitis B virus (HBV) infection (especially chronic) causes different glomerular, tubular, and interstitium damages. Membranous and membranoproliferative are the common HBV-associated nephropathy. The pathogenesis of HBV-associated nephropathy is primarily immune complex mediated; however, direct tubular damage may occur. The virus load and activity are essential risk factors in HBV-associated nephropathy development. Decreasing virus load and early treatment reduce the risk of HBV-associated nephropathy and may prevent the disease progression. Prevention of HBV infection by a worldwide vaccination program governed by the World Health Organization is the prime target to prevent hepatic and extrahepatic HBV-related complications. The authors searched the EMBASE, Google Scholar, Scopus, and Google search engines for articles about HBV-associated nephropathy using phrases, texts, and keywords such as chronic HBV infection and kidney, HBV-associated glomerulonephritis, nephritis in HBV infection, viral nephropathy, and HBV vaccination. Following multiple meetings and discussions, each author was given a section on the topic to search and summarize. Then, this narrative review manuscript has been written and revised to update HBV-associated nephropathy pathogenesis and treatment.
How to cite this article:
Habas E, Khan F, Farfar K, Habas A, Al Aldab A, Errayes M, Habas E, Kamal I, Rayani A, Elzouki AN. Hepatitis B virus-related nephropathy: Review and update.Libyan J Med Sci 2022;6:1-6
|
How to cite this URL:
Habas E, Khan F, Farfar K, Habas A, Al Aldab A, Errayes M, Habas E, Kamal I, Rayani A, Elzouki AN. Hepatitis B virus-related nephropathy: Review and update. Libyan J Med Sci [serial online] 2022 [cited 2023 Mar 30 ];6:1-6
Available from: https://www.ljmsonline.com/article.asp?issn=2588-9044;year=2022;volume=6;issue=1;spage=1;epage=6;aulast=Habas;type=0 |
|
